These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24078569)

  • 1. [Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome].
    Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):553-8. PubMed ID: 24078569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of genetic variations of cholesteryl ester transfer protein on atorvastatin treatment efficacy and clinical outcomes in patients with coronary artery disease].
    Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui RZ
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2195-9. PubMed ID: 24169327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease.
    Gu GL; Xu XL; Yang QY; Zeng RL
    Med Sci Monit; 2014 Dec; 20():2824-9. PubMed ID: 25547030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between cholesteryl ester transfer protein gene -629C→A mutations with HDL-C levels and coronary heart disease].
    Gao J; Mao YM; Cong HL; Liu Y; Zhang N; Chen Q; Liu T; Cui RZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):399-405. PubMed ID: 24021123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
    DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease.
    Li J; Zhang L; Xie NZ; Deng B; Lv LX; Zheng LQ
    Genet Mol Res; 2014 Mar; 13(1):2140-8. PubMed ID: 24737438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Jiang XC; Poirier O; Lackner KJ; Meyer J; Cambien F; Tiret L;
    J Am Coll Cardiol; 2003 Jun; 41(11):1983-9. PubMed ID: 12798569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment.
    Dullaart RP; van den Berg G; van der Knaap AM; Dijck-Brouwer J; Dallinga-Thie GM; Zelissen PM; Sluiter WJ; van Beek AP
    Eur J Endocrinol; 2010 Feb; 162(2):227-34. PubMed ID: 19926784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease.
    Ghatreh Samani K; Noori M; Rohbani Nobar M; Hashemzadeh Chaleshtori M; Farrokhi E; Darabi Amin M
    Iran Biomed J; 2009 Apr; 13(2):103-8. PubMed ID: 19471550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein (CETP) -629C/A polymorphism and it's effects on the serum lipid levels in metabolic syndrome patients.
    Akbarzadeh M; Hassanzadeh T; Saidijam M; Esmaeili R; Borzouei Sh; Hajilooi M; Mahjub H; Paoli M
    Mol Biol Rep; 2012 Oct; 39(10):9529-34. PubMed ID: 22729881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
    Khera AV; Wolfe ML; Cannon CP; Qin J; Rader DJ
    Am J Cardiol; 2010 Aug; 106(4):451-6. PubMed ID: 20691300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analytic evaluation of cholesteryl ester transfer protein (CETP) C-629A polymorphism in association with coronary heart disease risk and lipid changes.
    Lin S; Dai R; Lin R
    Oncotarget; 2017 Jan; 8(2):2153-2163. PubMed ID: 27791990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):349-54. PubMed ID: 22900989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer protein and ATP-binding cassette transporter A1 genotype alter the atorvastatin and simvastatin efficacy: time for genotype-guided therapy?
    Kolovou G; Kolovou V; Mihas C; Giannakopoulou V; Vasiliadis I; Boussoula E; Kollia A; Boutsikou M; Katsiki N; Mavrogeni S
    Angiology; 2013 May; 64(4):266-72. PubMed ID: 22584245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Bakker SJ; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.